Practice Fusion, Inc.; Analysis of Proposed Consent Order To Aid Public Comment, 39048-39049 [2016-14091]
Download as PDF
39048
Federal Register / Vol. 81, No. 115 / Wednesday, June 15, 2016 / Notices
1. Marquis Bancorp, Inc., to become a
bank holding company by acquiring 100
percent of the outstanding shares of
Marquis Bank, both in Coral Gables,
Florida.
B. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. First Mid-Illinois Bancshares, Inc.,
Mattoon, Illinois; to merge with First
Clover Leaf Financial Corp, and thereby
indirectly acquire First Clover Leaf
Bank, National Association, both in
Edwardsville, Illinois.
Board of Governors of the Federal Reserve
System, June 9, 2016.
Margaret M. Shanks,
Deputy Secretary of the Board.
[FR Doc. 2016–14088 Filed 6–14–16; 8:45 am]
BILLING CODE 6210–01–P
FEDERAL TRADE COMMISSION
[File No. 142 3039]
Practice Fusion, Inc.; Analysis of
Proposed Consent Order To Aid Public
Comment
Federal Trade Commission.
Proposed consent agreement.
AGENCY:
ACTION:
The consent agreement in this
matter settles alleged violations of
federal law prohibiting unfair or
deceptive acts or practices. The attached
Analysis to Aid Public Comment
describes both the allegations in the
draft complaint and the terms of the
consent order—embodied in the consent
agreement—that would settle these
allegations.
SUMMARY:
Comments must be received on
or before July 8, 2016.
ADDRESSES: Interested parties may file a
comment at https://
ftcpublic.commentworks.com/ftc/
practicefusionconsent online or on
paper, by following the instructions in
the Request for Comment part of the
SUPPLEMENTARY INFORMATION section
below. Write ‘‘Practice Fusion, Inc.—
Consent Agreement; File No. 142 3039’’
on your comment and file your
comment online at https://
ftcpublic.commentworks.com/ftc/
practicefusionconsent by following the
instructions on the web-based form. If
you prefer to file your comment on
paper, write ‘‘Practice Fusion, Inc.—
Consent Agreement; File No. 142 3039’’
on your comment and on the envelope,
and mail your comment to the following
address: Federal Trade Commission,
Office of the Secretary, 600
Pennsylvania Avenue NW., Suite CC–
ehiers on DSK5VPTVN1PROD with NOTICES
DATES:
VerDate Sep<11>2014
15:15 Jun 14, 2016
Jkt 238001
5610 (Annex D), Washington, DC 20580,
or deliver your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW.,
5th Floor, Suite 5610 (Annex D),
Washington, DC 20024.
FOR FURTHER INFORMATION CONTACT:
Allison Lefrak, Attorney, (202–326–
2804) or Ryan Mehm, Attorney, (202–
326–2918), Bureau of Consumer
Protection, 600 Pennsylvania Avenue
NW., Washington, DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 6(f) of the Federal Trade
Commission Act, 15 U.S.C. 46(f), and
FTC Rule 2.34, 16 CFR 2.34, notice is
hereby given that the above-captioned
consent agreement containing consent
order to cease and desist, having been
filed with and accepted, subject to final
approval, by the Commission, has been
placed on the public record for a period
of thirty (30) days. The following
Analysis to Aid Public Comment
describes the terms of the consent
agreement, and the allegations in the
complaint. An electronic copy of the
full text of the consent agreement
package can be obtained from the FTC
Home Page (for June 8, 2016), on the
World Wide Web at: https://www.ftc.gov/
os/actions.shtm.
You can file a comment online or on
paper. For the Commission to consider
your comment, we must receive it on or
before July 8, 2016. Write ‘‘Practice
Fusion, Inc.—Consent Agreement; File
No. 142 3039’’ on your comment. Your
comment—including your name and
your state—will be placed on the public
record of this proceeding, including, to
the extent practicable, on the public
Commission Web site, at https://
www.ftc.gov/os/publiccomments.shtm.
As a matter of discretion, the
Commission tries to remove individuals’
home contact information from
comments before placing them on the
Commission Web site.
Because your comment will be made
public, you are solely responsible for
making sure that your comment does
not include any sensitive personal
information, like anyone’s Social
Security number, date of birth, driver’s
license number or other state
identification number or foreign country
equivalent, passport number, financial
account number, or credit or debit card
number. You are also solely responsible
for making sure that your comment does
not include any sensitive health
information, like medical records or
other individually identifiable health
information. In addition, do not include
any ‘‘[t]rade secret or any commercial or
financial information which . . . is
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
privileged or confidential,’’ as discussed
in Section 6(f) of the FTC Act, 15 U.S.C.
46(f), and FTC Rule 4.10(a)(2), 16 CFR
4.10(a)(2). In particular, do not include
competitively sensitive information
such as costs, sales statistics,
inventories, formulas, patterns, devices,
manufacturing processes, or customer
names.
If you want the Commission to give
your comment confidential treatment,
you must file it in paper form, with a
request for confidential treatment, and
you have to follow the procedure
explained in FTC Rule 4.9(c), 16 CFR
4.9(c).1 Your comment will be kept
confidential only if the FTC General
Counsel, in his or her sole discretion,
grants your request in accordance with
the law and the public interest.
Postal mail addressed to the
Commission is subject to delay due to
heightened security screening. As a
result, we encourage you to submit your
comments online. To make sure that the
Commission considers your online
comment, you must file it at https://
ftcpublic.commentworks.com/ftc/
practicefusionconsent by following the
instructions on the web-based form. If
this Notice appears at https://
www.regulations.gov/#!home, you also
may file a comment through that Web
site.
If you file your comment on paper,
write ‘‘Practice Fusion, Inc.—Consent
Agreement; File No. 142 3039’’ on your
comment and on the envelope, and mail
your comment to the following address:
Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue
NW., Suite CC–5610 (Annex D),
Washington, DC 20580, or deliver your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, Constitution Center, 400 7th
Street SW., 5th Floor, Suite 5610
(Annex D), Washington, DC 20024. If
possible, submit your paper comment to
the Commission by courier or overnight
service.
Visit the Commission Web site at
https://www.ftc.gov to read this Notice
and the news release describing it. The
FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before July 8, 2016. You can find more
information, including routine uses
1 In particular, the written request for confidential
treatment that accompanies the comment must
include the factual and legal basis for the request,
and must identify the specific portions of the
comment to be withheld from the public record. See
FTC Rule 4.9(c), 16 CFR 4.9(c).
E:\FR\FM\15JNN1.SGM
15JNN1
Federal Register / Vol. 81, No. 115 / Wednesday, June 15, 2016 / Notices
ehiers on DSK5VPTVN1PROD with NOTICES
permitted by the Privacy Act, in the
Commission’s privacy policy, at https://
www.ftc.gov/ftc/privacy.htm.
Analysis of Proposed Consent Order To
Aid Public Comment
The Federal Trade Commission
(‘‘Commission’’) has accepted, subject to
final approval, an agreement containing
a consent order from Practice Fusion,
Inc. (‘‘Practice Fusion’’).
The proposed consent order has been
placed on the public record for thirty
(30) days for receipt of comments by
interested persons. Comments received
during this period will become part of
the public record. After thirty (30) days,
the Commission will again review the
agreement and the comments received,
and will decide whether it should
withdraw from the agreement or make
final the agreement’s proposed order.
Since 2007, Practice Fusion has
provided services for healthcare
providers. Since 2007, its core service
has been a cloud-based electronic health
record (‘‘EHR’’) that allows healthcare
providers in the ambulatory/out-patient
setting to store and utilize health
information. In 2009, Practice Fusion
launched the Patient Fusion Web site,
www.patientfusion.com (‘‘Patient
Fusion’’), with an online portal that
allows patients, who have been granted
access by their healthcare providers, to
view, download, and transmit to other
providers their health information and
send and receive secure messages
directly to their providers.
Practice Fusion planned to launch a
public-facing healthcare provider
directory portion of the Patient Fusion
Web site in 2013. The directory would,
among other things, allow current and
prospective patients to read patient
reviews of providers. To populate this
Web site with reviews, starting on April
5, 2012, Practice Fusion sent emails to
the patients of its healthcare provider
clients soliciting those patients to take
surveys to rate and review their
provider. The email—and the survey
itself—suggested that the health care
provider was directly seeking the survey
responses to improve the consumer’s
experience on future visits. Neither the
email nor the survey clearly indicated
that the reviews would be posted
publicly. Practice Fusion solicited
reviews for a full year—collecting
information from over 600,000 patients
during that time—before launching the
review service on April 8, 2013, at
which time all of the reviews previously
collected were posted publicly on the
Internet. Many of the reviews contained
highly sensitive information, combined
with identifying information, indicating
that many patients likely thought they
VerDate Sep<11>2014
15:15 Jun 14, 2016
Jkt 238001
were communicating directly with their
doctors, and did not intend for their
feedback to be posted publicly.
The Commission’s proposed
complaint alleges that Practice Fusion
violated Section 5(a) of the Federal
Trade Commission Act from April 2012
through April 2013 by failing to
adequately disclose that survey
responses would be made publicly
available on Patient Fusion’s healthcare
provider review Web site. This fact,
according to the proposed complaint,
would be material to consumers in
deciding whether or how to respond to
the survey. The Commission’s
complaint alleges that Practice Fusion’s
failure to adequately disclose this
material information is a deceptive act
or practice in violation of Section 5.
The proposed order contains
provisions designed to prevent Practice
Fusion from engaging in the same or
similar acts or practices in the future.
Part I of the proposed order prohibits
Practice Fusion from misrepresenting
the extent to which it uses, maintains,
and protects the privacy and
confidentiality of any covered
information, including the extent to
which covered information is made
publicly available.
Part II of the proposed order requires
Practice Fusion, prior to making any
consumer’s covered information
publicly available, to (A) clearly and
conspicuously disclose to the consumer,
separate and apart from ‘‘privacy
policy,’’ ‘‘terms of use’’ page, or similar
document, that such information is
being made publicly available; and (B)
obtain the consumer’s affirmative
express consent.
Part III of the proposed order
prohibits Practice Fusion from
displaying any healthcare provider
review information obtained from
consumers between April 5, 2012 and
April 8, 2013. Part III of the proposed
order also prohibits Practice Fusion
from maintaining such information,
except for review and retrieval by its
healthcare provider customers, or their
respective agents, contractors, assigns,
or as permitted to comply with
applicable law, regulation, or legal
process.
Parts IV through VIII of the proposed
order are reporting and compliance
provisions. Part IV requires
acknowledgment of the order and
dissemination of the order now and in
the future to persons with supervisory
responsibilities relating to the subject
matter of the order. Part V ensures
notification to the FTC of changes in
corporate status and mandates that
Practice Fusion submit an initial
compliance report to the FTC. Part VI
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
39049
requires Practice Fusion to retain
documents relating to its compliance
with the order for a five-year period.
Part VII mandates that Practice Fusion
make available to the FTC information
or subsequent compliance reports, as
requested. Part VIII is a provision
‘‘sunsetting’’ the order after twenty (20)
years, with certain exceptions.
The purpose of this analysis is to aid
public comment on the proposed order.
It is not intended to constitute an
official interpretation of the complaint
or proposed order, or to modify in any
way the proposed order’s terms.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2016–14091 Filed 6–14–16; 8:45 am]
BILLING CODE 6750–01–P
FEDERAL TRADE COMMISSION
[File No. 151 0172]
Energy Transfer Equity, L.P. and The
Williams Companies, Inc.; Analysis To
Aid Public Comment
Federal Trade Commission.
Proposed consent agreement.
AGENCY:
ACTION:
The consent agreement in this
matter settles alleged violations of
federal law prohibiting unfair methods
of competition. The attached Analysis to
Aid Public Comment describes both the
allegations in the complaint and the
terms of the consent orders—embodied
in the consent agreement—that would
settle these allegations.
DATES: Comments must be received on
or before July 11, 2016.
ADDRESSES: Interested parties may file a
comment at https://
ftcpublic.commentworks.com/ftc/
energytransferequityconsent online or
on paper, by following the instructions
in the Request for Comment part of the
SUPPLEMENTARY INFORMATION section
below. Write ‘‘In the Matter of Energy
Transfer Equity, L.P.,—Consent
Agreement; File No. 151 0172’’ on your
comment and file your comment online
at https://ftcpublic.commentworks.com/
ftc/energytransferequityconsent by
following the instructions on the webbased form. If you prefer to file your
comment on paper, write ‘‘In the Matter
of Energy Transfer Equity, L.P.,—
Consent Agreement; File No. 151 0172’’
on your comment and on the envelope,
and mail your comment to the following
address: Federal Trade Commission,
Office of the Secretary, 600
Pennsylvania Avenue NW., Suite CC–
5610 (Annex D), Washington, DC 20580,
or deliver your comment to the
SUMMARY:
E:\FR\FM\15JNN1.SGM
15JNN1
Agencies
[Federal Register Volume 81, Number 115 (Wednesday, June 15, 2016)]
[Notices]
[Pages 39048-39049]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14091]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
[File No. 142 3039]
Practice Fusion, Inc.; Analysis of Proposed Consent Order To Aid
Public Comment
AGENCY: Federal Trade Commission.
ACTION: Proposed consent agreement.
-----------------------------------------------------------------------
SUMMARY: The consent agreement in this matter settles alleged
violations of federal law prohibiting unfair or deceptive acts or
practices. The attached Analysis to Aid Public Comment describes both
the allegations in the draft complaint and the terms of the consent
order--embodied in the consent agreement--that would settle these
allegations.
DATES: Comments must be received on or before July 8, 2016.
ADDRESSES: Interested parties may file a comment at https://ftcpublic.commentworks.com/ftc/practicefusionconsent online or on
paper, by following the instructions in the Request for Comment part of
the SUPPLEMENTARY INFORMATION section below. Write ``Practice Fusion,
Inc.--Consent Agreement; File No. 142 3039'' on your comment and file
your comment online at https://ftcpublic.commentworks.com/ftc/practicefusionconsent by following the instructions on the web-based
form. If you prefer to file your comment on paper, write ``Practice
Fusion, Inc.--Consent Agreement; File No. 142 3039'' on your comment
and on the envelope, and mail your comment to the following address:
Federal Trade Commission, Office of the Secretary, 600 Pennsylvania
Avenue NW., Suite CC-5610 (Annex D), Washington, DC 20580, or deliver
your comment to the following address: Federal Trade Commission, Office
of the Secretary, Constitution Center, 400 7th Street SW., 5th Floor,
Suite 5610 (Annex D), Washington, DC 20024.
FOR FURTHER INFORMATION CONTACT: Allison Lefrak, Attorney, (202-326-
2804) or Ryan Mehm, Attorney, (202-326-2918), Bureau of Consumer
Protection, 600 Pennsylvania Avenue NW., Washington, DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant to Section 6(f) of the Federal
Trade Commission Act, 15 U.S.C. 46(f), and FTC Rule 2.34, 16 CFR 2.34,
notice is hereby given that the above-captioned consent agreement
containing consent order to cease and desist, having been filed with
and accepted, subject to final approval, by the Commission, has been
placed on the public record for a period of thirty (30) days. The
following Analysis to Aid Public Comment describes the terms of the
consent agreement, and the allegations in the complaint. An electronic
copy of the full text of the consent agreement package can be obtained
from the FTC Home Page (for June 8, 2016), on the World Wide Web at:
https://www.ftc.gov/os/actions.shtm.
You can file a comment online or on paper. For the Commission to
consider your comment, we must receive it on or before July 8, 2016.
Write ``Practice Fusion, Inc.--Consent Agreement; File No. 142 3039''
on your comment. Your comment--including your name and your state--will
be placed on the public record of this proceeding, including, to the
extent practicable, on the public Commission Web site, at https://www.ftc.gov/os/publiccomments.shtm. As a matter of discretion, the
Commission tries to remove individuals' home contact information from
comments before placing them on the Commission Web site.
Because your comment will be made public, you are solely
responsible for making sure that your comment does not include any
sensitive personal information, like anyone's Social Security number,
date of birth, driver's license number or other state identification
number or foreign country equivalent, passport number, financial
account number, or credit or debit card number. You are also solely
responsible for making sure that your comment does not include any
sensitive health information, like medical records or other
individually identifiable health information. In addition, do not
include any ``[t]rade secret or any commercial or financial information
which . . . is privileged or confidential,'' as discussed in Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR
4.10(a)(2). In particular, do not include competitively sensitive
information such as costs, sales statistics, inventories, formulas,
patterns, devices, manufacturing processes, or customer names.
If you want the Commission to give your comment confidential
treatment, you must file it in paper form, with a request for
confidential treatment, and you have to follow the procedure explained
in FTC Rule 4.9(c), 16 CFR 4.9(c).\1\ Your comment will be kept
confidential only if the FTC General Counsel, in his or her sole
discretion, grants your request in accordance with the law and the
public interest.
---------------------------------------------------------------------------
\1\ In particular, the written request for confidential
treatment that accompanies the comment must include the factual and
legal basis for the request, and must identify the specific portions
of the comment to be withheld from the public record. See FTC Rule
4.9(c), 16 CFR 4.9(c).
---------------------------------------------------------------------------
Postal mail addressed to the Commission is subject to delay due to
heightened security screening. As a result, we encourage you to submit
your comments online. To make sure that the Commission considers your
online comment, you must file it at https://ftcpublic.commentworks.com/ftc/practicefusionconsent by following the instructions on the web-
based form. If this Notice appears at https://www.regulations.gov/#!home, you also may file a comment through that Web site.
If you file your comment on paper, write ``Practice Fusion, Inc.--
Consent Agreement; File No. 142 3039'' on your comment and on the
envelope, and mail your comment to the following address: Federal Trade
Commission, Office of the Secretary, 600 Pennsylvania Avenue NW., Suite
CC-5610 (Annex D), Washington, DC 20580, or deliver your comment to the
following address: Federal Trade Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW., 5th Floor, Suite 5610 (Annex
D), Washington, DC 20024. If possible, submit your paper comment to the
Commission by courier or overnight service.
Visit the Commission Web site at https://www.ftc.gov to read this
Notice and the news release describing it. The FTC Act and other laws
that the Commission administers permit the collection of public
comments to consider and use in this proceeding as appropriate. The
Commission will consider all timely and responsive public comments that
it receives on or before July 8, 2016. You can find more information,
including routine uses
[[Page 39049]]
permitted by the Privacy Act, in the Commission's privacy policy, at
https://www.ftc.gov/ftc/privacy.htm.
Analysis of Proposed Consent Order To Aid Public Comment
The Federal Trade Commission (``Commission'') has accepted, subject
to final approval, an agreement containing a consent order from
Practice Fusion, Inc. (``Practice Fusion'').
The proposed consent order has been placed on the public record for
thirty (30) days for receipt of comments by interested persons.
Comments received during this period will become part of the public
record. After thirty (30) days, the Commission will again review the
agreement and the comments received, and will decide whether it should
withdraw from the agreement or make final the agreement's proposed
order.
Since 2007, Practice Fusion has provided services for healthcare
providers. Since 2007, its core service has been a cloud-based
electronic health record (``EHR'') that allows healthcare providers in
the ambulatory/out-patient setting to store and utilize health
information. In 2009, Practice Fusion launched the Patient Fusion Web
site, www.patientfusion.com (``Patient Fusion''), with an online portal
that allows patients, who have been granted access by their healthcare
providers, to view, download, and transmit to other providers their
health information and send and receive secure messages directly to
their providers.
Practice Fusion planned to launch a public-facing healthcare
provider directory portion of the Patient Fusion Web site in 2013. The
directory would, among other things, allow current and prospective
patients to read patient reviews of providers. To populate this Web
site with reviews, starting on April 5, 2012, Practice Fusion sent
emails to the patients of its healthcare provider clients soliciting
those patients to take surveys to rate and review their provider. The
email--and the survey itself--suggested that the health care provider
was directly seeking the survey responses to improve the consumer's
experience on future visits. Neither the email nor the survey clearly
indicated that the reviews would be posted publicly. Practice Fusion
solicited reviews for a full year--collecting information from over
600,000 patients during that time--before launching the review service
on April 8, 2013, at which time all of the reviews previously collected
were posted publicly on the Internet. Many of the reviews contained
highly sensitive information, combined with identifying information,
indicating that many patients likely thought they were communicating
directly with their doctors, and did not intend for their feedback to
be posted publicly.
The Commission's proposed complaint alleges that Practice Fusion
violated Section 5(a) of the Federal Trade Commission Act from April
2012 through April 2013 by failing to adequately disclose that survey
responses would be made publicly available on Patient Fusion's
healthcare provider review Web site. This fact, according to the
proposed complaint, would be material to consumers in deciding whether
or how to respond to the survey. The Commission's complaint alleges
that Practice Fusion's failure to adequately disclose this material
information is a deceptive act or practice in violation of Section 5.
The proposed order contains provisions designed to prevent Practice
Fusion from engaging in the same or similar acts or practices in the
future. Part I of the proposed order prohibits Practice Fusion from
misrepresenting the extent to which it uses, maintains, and protects
the privacy and confidentiality of any covered information, including
the extent to which covered information is made publicly available.
Part II of the proposed order requires Practice Fusion, prior to
making any consumer's covered information publicly available, to (A)
clearly and conspicuously disclose to the consumer, separate and apart
from ``privacy policy,'' ``terms of use'' page, or similar document,
that such information is being made publicly available; and (B) obtain
the consumer's affirmative express consent.
Part III of the proposed order prohibits Practice Fusion from
displaying any healthcare provider review information obtained from
consumers between April 5, 2012 and April 8, 2013. Part III of the
proposed order also prohibits Practice Fusion from maintaining such
information, except for review and retrieval by its healthcare provider
customers, or their respective agents, contractors, assigns, or as
permitted to comply with applicable law, regulation, or legal process.
Parts IV through VIII of the proposed order are reporting and
compliance provisions. Part IV requires acknowledgment of the order and
dissemination of the order now and in the future to persons with
supervisory responsibilities relating to the subject matter of the
order. Part V ensures notification to the FTC of changes in corporate
status and mandates that Practice Fusion submit an initial compliance
report to the FTC. Part VI requires Practice Fusion to retain documents
relating to its compliance with the order for a five-year period. Part
VII mandates that Practice Fusion make available to the FTC information
or subsequent compliance reports, as requested. Part VIII is a
provision ``sunsetting'' the order after twenty (20) years, with
certain exceptions.
The purpose of this analysis is to aid public comment on the
proposed order. It is not intended to constitute an official
interpretation of the complaint or proposed order, or to modify in any
way the proposed order's terms.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2016-14091 Filed 6-14-16; 8:45 am]
BILLING CODE 6750-01-P